Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Upstream Bio (UPB US)
Watchlist
1
Analysis
Health Care
•
United States
Upstream Bio, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. Upstream Bio serves customers in the United States.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Upstream Bio
•
25 Sep 2024 03:23
Upstream Bio IPO Preview: Severe Asthma/CRSwNP Program Advancing
Upstream Bio, a clinical-stage biotech company focused on severe asthma, CRSwNP, COPD, filed for US IPO. Their ex-Astellas monoclonal antibody,...
Andrei Zakharov
Follow
227 Views
Share
No more insights
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.36.7
x